Part 8: Fluid Therapy in Medical Disorders

38: Acute Pancreatitis

 

Chapter outlines

Causes and Diagnosis
Classification
Management
Initial medical management
- Control of pain
- Fluid resuscitation
- Electrolyte and metabolic disorders
- Nutrition
- Antibiotics
- Other drugs
Endoscopy therapy
Surgical therapy

INTRODUCTION

Acute pancreatitis (AP) is a common gastrointestinal tract disease that occurs due to cellular injury and inflammation of the pancreas and is characterized by the abrupt onset of deep epigastric pain and elevated levels of lipase or amylase levels in the blood [1, 2]. Acute pancreatitis is increasing globally; it is one of the most common gastrointestinal causes of hospitalization in the United States and is associated with significant morbidity, mortality, and substantial health care cost [3–5].

CAUSES

The most common causes of acute pancreatitis are gallstones (about 42%) and chronic alcohol use (about 21%), while less frequent causes are hypertriglyceridemia, post-endoscopic retrograde cholangiopancreatography, hypercalcemia, trauma, infection, and idiopathic [6, 7].

DIAGNOSIS

The diagnosis of acute pancreatitis requires at least two of the following three criteria: (1) Typical abdominal pain (acute onset severe, persistent, epigastric, and left upper quadrant abdominal pain); (2) Threefold elevation in pancreatic enzymes activity (serum lipase and serum amylase); and (3) Imaging (computerized tomography [CT], magnetic resonance imaging [MRI], ultrasound) findings that are consistent with acute pancreatitis [8].

CLASSIFICATION

Based on pathological changes, onset, and severity, acute pancreatitis is classified in Table 38.1 [3, 8–16].

MANAGEMENT

Treatment of acute pancreatitis should be individualized depending on the severity of the disease, causative etiology, presence of complications of severe acute pancreatitis, and coexisting disorders. Management of acute pancreatitis is divided into three broad categories:
A. Initial medical management
B. Endoscopy therapy
C. Surgical therapy

REFERENCES

  1. Johnson CD, Besselink MG, Carter R. Acute pancreatitis. BMJ. 2014;349:g4859.
  2. Crockett SD, Wani S, Gardner TB, et al. American Gastroenterological Association Institute Clinical Guidelines Committee. American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis. Gastroenterology. 2018;154(4):1096–1101.
  3. Forsmark CE, Vege SS, Wilcox CM, et al. Acute pancreatitis. N Engl J Med 2016;375(20):1972–1981.
  4. Peery AF, Crockett SD, Murphy CC, et al. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. Gastroenterology. 2019;156(1):254–272.e11.
  5. Petrov MS, Yadav D. Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):175–184.
  6. Zilio MB, Eyff TF, Azeredo-Da-Silva ALF, et al. A systematic review and meta-analysis of the aetiology of acute pancreatitis. HPB (Oxford). 2019;21(3):259–267.
  7. Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis. Lancet 2020;396(10252):726–734.
  8. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–11.
  9. Tenner S, Baillie J, DeWitt J, et al. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol 2013;108(9):1400–1415.
  10. Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013;13(4 suppl 2):e1–15.
  11. Phillip V, Steiner JM, Algül H. Early phase of acute pancreatitis: Assessment and management. World J Gastrointest Pathophysiol. 2014;5(3):158–68.
  12. Yokoe M, Takada T, Mayumi T, et al. Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015. J Hepatobiliary Pancreat Sci. 2015;22(6):405–32.
  13. Greenberg JA, Hsu J, Bawazeer M, et al. Clinical practice guideline: management of acute pancreatitis. Can J Surg. 2016;59(2):128–140.
  14. Boumitri C, Brown E, Kahaleh M. Necrotizing Pancreatitis: Current Management and Therapies. Clin Endosc. 2017;50(4):357–365.
  15. Leppäniemi A, Tolonen M, Tarasconi A, et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg 2019;14:27.
  16. Seppänen H, Puolakkainen P. Classification, Severity Assessment, and Prevention of Recurrences in Acute Pancreatitis. Scandinavian Journal of Surgery. 2020;109(1):53–58.
  17. Lakananurak N, Gramlich L. Nutrition management in acute pancreatitis: Clinical practice consideration. World J Clin Cases. 2020;8(9):1561–1573.
  18. Nelson AD, Lugo-Fagundo NS, Mahapatra SJ, et al. A Systematic Review and Meta-analysis of Opioids vs Nonopioids in Acute Pancreatitis. Gastro Hep Advances 2022;1(1):83–92.
  19. Thavanesan N, White S, Lee S, et al. Analgesia in the Initial Management of Acute Pancreatitis: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. World J Surg. 2022;46(4):878–890.
  20. Cai W, Liu F, Wen Y, et al. Pain Management in Acute Pancreatitis: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Front Med (Lausanne). 2021;8:782151.
  21. Basurto Ona X, Rigau Comas D, Urrútia G. Opioids for acute pancreatitis pain. Cochrane Database Syst Rev. 2013;(7):CD009179.
  22. Stigliano S, Sternby H, de Madaria E, et al. Early management of acute pancreatitis: a review of the best evidence. Digestive and Liver Disease. 2017;49(6):585–594.
  23. Meng W, Yuan J, Zhang C, et al. Parenteral analgesics for pain relief in acute pancreatitis: a systematic review. Pancreatology. 2013;13(3):201–206.
  24. Barlass U, Dutta R, Cheema H, et al. Morphine worsens the severity and prevents pancreatic regeneration in mouse models of acute pancreatitis. Gut 2017;67:600–602.
  25. Gülen B, Dur A, Serinken M, et al. Pain treatment in patients with acute pancreatitis: a randomized controlled trial. Turk J Gastroenterol 2016;27(2):192–6.
  26. Li F, Cai S, Cao F, et al. Guidelines for the diagnosis and treatment of acute pancreatitis in China (2021). Journal of Pancreatology. 2021;4(2):67–75.
  27. Gardner TB, Vege SS, Pearson RK, et al. Fluid resuscitation in acute pancreatitis. Clin Gastroenterol Hepatol. 2008;6(10):1070–6.
  28. Talukdar R, Swaroop Vege S. Early management of severe acute pancreatitis. Curr Gastroenterol Rep 2011;13(2):123–30.
  29. Warndorf MG, Kurtzman JT, Bartel MJ, et al. Early fluid resuscitation reduces morbidity among patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011;9(8):705–709.
  30. Haydock MD, Mittal A, Wilms HR, et al. Fluid therapy in acute pancreatitis: anybody’s guess. Ann Surg 2013;257(2):182–188.
  31. Gardner TB, Vege SS, Chari ST, et al. Faster rate of initial fluid resuscitation in severe acute pancreatitis diminishes in-hospital mortality. Pancreatology 2009;9(6):770–776.
  32. Wall I, Badalov N, Baradarian R, et al. Decreased morbidity and mortality in patients with acute pancreatitis related to aggressive intravenous hydration. Pancreas 2011;40(4):547–50.
  33. Buxbaum JL, Quezada M, Da B, et al. Early aggressive hydration hastens clinical improvement in mild acute pancreatitis. Am J Gastroenterol 2017;112(5):797–803.
  34. Yamashita T, Horibe M, Sanui M, et al. Large Volume Fluid Resuscitation for Severe Acute Pancreatitis is Associated with Reduced Mortality: A Multicenter Retrospective Study. J Clin Gastroenterol. 2019;53(5):385–391.
  35. Fisher JM, Gardner TB. The “golden hours” of management in acute pancreatitis. Am J Gastroenterol. 2012;107(8):1146–1150.
  36. Mao EQ, Tang YQ, Fei J, et al. Fluid therapy for severe acute pancreatitis in acute response stage. Chin Med J (Engl) 2009;122(2):169–73.
  37. Mao EQ, Fei J, Peng YB, et al. Rapid hemodilution is associated with increased sepsis and mortality among patients with severe acute pancreatitis. Chin Med J (Engl) 2010;123(13):1639–44.
  38. de-Madaria E, Soler-Sala G, Sánchez-Paya J, et al. Influence of fluid therapy on the prognosis of acute pancreatitis: a prospective cohort study. Am J Gastroenterol 2011;106(10):1843–50.
  39. Ye B, Mao W, Chen Y, et al. Aggressive Resuscitation Is Associated with the Development of Acute Kidney Injury in Acute Pancreatitis. Dig Dis Sci. 2019;64(2):544–552.
  40. Li L, Jin T, Wen S, et al. Early rapid fluid therapy is associated with increased rate of noninvasive positive-pressure ventilation in Hemoconcentrated patients with severe acute pancreatitis. Dig Dis Sci. United States. 2020;65(9):2700–11.
  41. Messallam AA, Body CB, Berger S, et al. Impact of early aggressive fluid resuscitation in acute pancreatitis. Pancreatology. 2021;21(1):69–73.
  42. Gad MM, Simons-Linares CR. Is aggressive intravenous fluid resuscitation beneficial in acute pancreatitis? A meta-analysis of randomized control trials and cohort studies. World J Gastroenterol. 2020;26(10):1098–1106.
  43. Liao J, Zhan Y, Wu H, et al. Effect of aggressive versus conservative hydration for early phase of acute pancreatitis in adult patients: A meta-analysis of 3,127 cases. Pancreatology. 2022;22(2):226–234.
  44. E de-Madaria JL, Buxbaum P, Maisonneuve A, et al. Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis. N Engl J Med 2022;387:989–1000.
  45. Argaiz ER, de Moraes AG. Acute pancreatitis. Lancet. 2021;397(10271):279.
  46. Boxhoorn L, Voermans RP, van Santvoort HC, et al. Acute pancreatitis. Lancet. 2021;397(10271):280.
  47. Wu BU, Hwang JQ, Gardner TH, et al. Lactated Ringer’s solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011;9(8):710–717.e1.
  48. Gardnet TB. Fluid Resuscitation in Acute Pancreatitis - Going over the WATERFALL. N Engl J Med 2022;387(11):1038–1039.
  49. Cuéllar-Monterrubio JE, Monreal-Robles R, González-Moreno EI, et al. Nonaggressive Versus Aggressive Intravenous Fluid Therapy in Acute Pancreatitis With More Than 24 Hours From Disease Onset: A Randomized Controlled Trial. Pancreas. 2020;49(4):579–583.
  50. Aziz M, Ahmed Z, Weissman S, et al. Lactated Ringer’s vs normal saline for acute pancreatitis: An updated systematic review and meta-analysis. Pancreatology. 2021;21(7):1217–1223.
  51. Lee A, Ko C, Buitrago C, et al. Lactated Ringers vs Normal Saline Resuscitation for Mild Acute Pancreatitis: A Randomized Trial. Gastroenterology. 2021;160(3):955–957.e4.
  52. Chen H, Lu X, Xu B, et al. Lactated Ringer Solution Is Superior to Normal Saline Solution in Managing Acute Pancreatitis: An Updated Meta-analysis of Randomized Controlled Trials. J Clin Gastroenterol 2022;56(2):e114–e120.
  53. Guzmán-Calderón E, Diaz-Arocutipa C, Monge E. Lactate Ringer’s Versus Normal Saline in the Management of Acute Pancreatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Dig Dis Sci. 2022;67(8):4131–4139.
  54. de-Madaria E, Herrera-Marante I, González-Camacho V, et al. Fluid resuscitation with lactated Ringer’s solution vs normal saline in acute pancreatitis: a triple-blind, randomized, controlled trial. United European Gastroenterol J. 2018;6(1):63–72.
  55. Iqbal U, Anwar H, Scribani M. Ringer’s lactate versus normal saline in acute pancreatitis: a systematic review and meta-analysis. J Dig Dis. 2018;19(6):335–341.
  56. Khatua B, Yaron JR, El-Kurdi B, et al. Ringer’s Lactate Prevents Early Organ Failure by Providing Extracellular Calcium. J Clin Med 2020;9(1):263.
  57. Karki B, Thapa S, Khadka D, et al. Intravenous Ringers lactate versus normal saline for predominantly mild acute pancreatitis in a Nepalese Tertiary Hospital. PLoS One. 2022;17(1):e0263221.
  58. Zhou S, Buitrago C, Foong A, et al. Comprehensive meta-analysis of randomized controlled trials of lactated Ringer’s versus normal saline for acute pancreatitis. Pancreatology 2021;21(8):1405–1410.
  59. Semler MW, Self WH, Wanderer JP, et al. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med. 2018;378(9):829–839.
  60. Kellum JA. Saline-induced hyperchloremic metabolic acidosis. Crit Care Med 2002;30(1):259–261.
  61. Reid F, Lobo DN, Williams RN, et al. (Ab)normal saline and physiological Hartmann’s solution: a randomized double-blind crossover study. Clin Sci (Lond) 2003;104(1):17–24.
  62. Bhoomagoud M, Jung T, Atladottir J, et al. Reducing extracellular pH sensitizes the acinar cell to secretagogue-induced pancreatitis responses in rats. Gastroenterology 2009;137(3):1083–1092.
  63. Du XJ, Hu WM, Xia Q, et al. Hydroxyethyl starch resuscitation reduces the risk of intra-abdominal hypertension in severe acute pancreatitis. Pancreas 2011;40(8):1220–1225.
  64. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367(20):1901–1911.
  65. Zhao G, Zhang JG, Wu HS, et al. Effects of different resuscitation fluid on severe acute pancreatitis. World J Gastroenterol 2013;19(13):2044–2052.
  66. Browne GW, Pitchumoni CS. Pathophysiology of pulmonary complications of acute pancreatitis. World J Gastroenterol. 2006;12(44):7087–96.
  67. Takeda K, Takada T, Kawarada Y, et al. JPN Guidelines for the management of acute pancreatitis: medical management of acute pancreatitis. J Hepatobiliary Pancreat Surg. 2006;13(1):42–7.
  68. Huber W, Umgelter A, Reindl W, et al. Volume assessment in patients with necrotizing pancreatitis: a comparison of intrathoracic blood volume index, central venous pressure, and hematocrit, and their correlation to cardiac index and extravascular lung water index. Crit Care Med. 2008;36(8):2348–54.
  69. Gutiérrez-Jiménez AA, Castro-Jiménez E, Lagunes-Córdoba R. Total serum calcium and corrected calcium as severity predictors in acute pancreatitis. Rev Gastroenterol Mex 2014;79(1):13–21.
  70. Chhabra P, Rana SS, Sharma V, et al. Hypocalcemic tetany: a simple bedside marker of poor outcome in acute pancreatitis. Ann Gastroenterol. 2016;29(2):214–20.
  71. Ahmed A, Azim A, Gurjar M, et al. Hypocalcemia in acute pancreatitis revisited. Indian J Crit Care Med. 2016;20(3):173–7.
  72. Hersh T, Siddiqui DA. Magnesium and the pancreas. Am J Clin Nutr. 1973;26(3):362–366.
  73. Xiu F, Stanojcic M, Diao L, et al. Stress hyperglycemia, insulin treatment, and innate immune cells. Int J Endocrinol. 2014;2014:486403.
  74. Zhi M, Zhu X, Lugea A, et al. Incidence of New Onset Diabetes Mellitus Secondary to Acute Pancreatitis: A Systematic Review and Meta-Analysis. Frontiers in physiology. 2019;10:637.
  75. Das SL, Singh PP, Phillips AR, et al. Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis. Gut. 2014;63(5):818–31.
  76. Liu QP, Hu CL, Chen NW. New-Onset Diabetes Mellitus After the First Attack of Acute Pancreatitis: A Systematic Review and Meta-Analysis. Iran Red Crescent Med J. 2019;21(7):e91740.
  77. Tu J, Yang Y, Zhang J, et al. Effect of the disease severity on the risk of developing new-onset diabetes after acute pancreatitis. Medicine (Baltimore). 2018;97(22):e10713.
  78. Hart PA, Bradley D, Conwell DL, et al. Diabetes following acute pancreatitis. Lancet Gastroenterol Hepatol. 2021;6(8):668–675.
  79. Richardson A, Park WG. Acute pancreatitis and diabetes mellitus: a review. Korean J Intern Med. 2021;36(1):15–24.
  80. Uomo G. Pancreatic rest or not? The debate on the nutrition in acute pancreatitis continues. JOP. 2013;14(2):216–7.
  81. Rinninella, E, Annetta MG, Serricchio M et al. Nutritional support in acute pancreatitis: from physiopathology to practice: an evidence-based approach. Eur Rev Med Pharmacol Sci 2017;21(2):421–432.
  82. Al-Omran M, Albalawi ZH, Tashkandi MF, et al. Enteral versus parenteral nutrition for acute pancreatitis. Cochrane Database Syst Rev 2010;2010(1):CD002837.
  83. Vaughn VM, Shuster D, Rogers MAM, et al. Early versus delayed feeding in patients with acute pancreatitis: a systematic review. Ann Intern Med. 2017;166(12):883–892.
  84. Li W, Liu J, Zhao S, et al. Safety and efcacy of total parenteral nutrition versus total enteral nutrition for patients with severe acute pancreatitis: a meta-analysis. J Int Med Res 2018;46(9):3948–3958.
  85. Wu P, Li L, Sun W. Efficacy comparisons of enteral nutrition and parenteral nutrition in patients with severe acute pancreatitis: a meta-analysis from randomized controlled trials. Biosci Rep 2018;38(6):BSR20181515.
  86. Yao H, He C, Deng L, et al. Enteral versus parenteral nutrition in critically ill patients with severe pancreatitis: a meta-analysis. Eur J Clin Nutr 2018;72(1):66–68.
  87. National Institute for Health and Care Excellence. Pancreatitis (NICE guideline NG104). 2018. www.nice.org.uk/guidance/ng104.
  88. Arvanitakis M, Ockenga J, Bezmarevic M, et al. ESPEN guideline on clinical nutrition in acute and chronic pancreatitis. Clin Nutr. 2020;39(3):612–631.
  89. Guo QH, Tian XY, Qin YL, et al. Immediate enteral nutrition can accelerate recovery and be safe in mild acute pancreatitis: A meta-analysis of randomized controlled trials. Heliyon. 2022;8(2):e08852.
  90. Yao Q, Liu P, Peng S, et al. Effects of immediate or early oral feeding on acute pancreatitis: a systematic review and metaanalysis. Pancreatology. 2022;22(2):175–184.
  91. Vlada AC, Schmit B, Perry A, et al. Failure to follow evidence-based best practice guidelines in the treatment of severe acute pancreatitis. HPB (Oxford) 2013;15(10):822–7.
  92. Sun E, Tharakan M, Kapoor S, et al. Poor compliance with ACG guidelines for nutrition and antibiotics in the management of acute pancreatitis: a North American survey of gastrointestinal specialists and primary care physicians. JOP 2013;14(3):221–7.
  93. Parniczky A, Lantos T, Toth EM, et al. Antibiotic therapy in acute pancreatitis: from global overuse to evidence based recommendations. Pancreatology. 2019;19(4):488–99.
  94. Nakaharai K, Morita K, Jo T, et al. Early prophylactic antibiotics for severe acute pancreatitis: a population-based cohort study using a nationwide database in Japan. J Infect Chemother 2018;24(9):753–758.
  95. Horibe M, Sanui M, Sasaki M, et al. Impact of antimicrobial prophylaxis for severe acute pancreatitis on the development of invasive candidiasis: a large retrospective multicenter cohort study. Pancreas. 2019;48(4):537–43.
  96. Isenmann R, Runzi M, Kron M, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double blind trial. Gastroenterology. 2004;126(4):997–1004.
  97. Dellinger EP, Tellado JM, Soto NE, et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: randomized, double-blind, placebo-controlled study. Ann Surg. 2007;245(5):674–83.
  98. Mandal AK, Chaudhary S, Shrestha B, et al. Efficacy of prophylactic use of ciprofloxacin and metronidazole in mild and moderately severe acute pancreatitis. JNMA J Nepal Med Assoc 2017;56(206):207–210.
  99. Jafri NS, Mahid SS, Idstein SR, et al. Antibiotic prophylaxis is not protective in severe acute pancreatitis: a systemic review and meta-analysis. Am J Surg 2009;197(6):806–813.
  100. Villatoro E, Bassi C, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2010;(5):CD002941.
  101. Lim CL, Lee W, Liew YX, et al. Role of antibiotic prophylaxis in necrotizing pancreatitis: a meta-analysis. J Gastrointest Surg 2015;19(3):480–91.
  102. Mourad MM, Evans R, Kalidindi V, et al. Prophylactic antibiotics in acute pancreatitis: endless debate. Ann R Coll Surg Engl 2017;99(2):107–112.
  103. Mofidi R, Suttie SA, Patil PV, et al. The value of procalcitonin at predicting the severity of acute pancreatitis and development of infected pancreatic necrosis: systematic review. Surgery. 2009;146(1):72–81.
  104. Manes G, Rabitti PG, Menchise A, et al. Prophylaxis with meropenem of septic complications in acute pancreatitis: a randomized, controlled trial versus imipenem. Pancreas. 2003;27(4):e79–83.
  105. van Baal MC, Besselink MG, Bakker OJ, et al. Dutch Pancreatitis Study Group. Timing of cholecystectomy after mild biliary pancreatitis: a systematic review. Ann Surg. 2012;255(5):860–866.
  106. Hwang SS, Li BH, Haigh PI. Gallstone pancreatitis without cholecystectomy. JAMA Surg. 2013;148(9):867–872.
  107. Uhl W, Müller CA, Krähenbühl L, et al. Acute gallstone pancreatitis: timing of laparoscopic cholecystectomy in mild and severe disease. Surg Endosc 1999;13(11):1070–6.
  108. Aboulian A, Chan T, Yaghoubian A, et al. Early cholecystectomy safely decreases hospital stay in patients with mild gallstone pancreatitis: a randomized prospective study. Ann Surg 2010;251(4):615–9.
  109. da Costa DW, Bouwense SA, Schepers NJ, et al. Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): a multicentre randomised controlled trial. Lancet 2015;386(10000):1261–1268.
  110. Laswi H, Attara B, Kwei R, et al. Readmissions after Biliary Acute Pancreatitis: Analysis of the Nationwide Readmissions Database. Gastroenterology Research 2022;15(4):188–199.
  111. Lyu Y, Cheng Y, Wang B, et al. Safety of early same-admission laparoscopic cholecystectomy for acute mild biliary pancreatitis. A retrospective study for acute pancreatitis. Wideochir Inne Tech Maloinwazyjne. 2022;17(1):150–155.
TABLE OF CONTENTS